Charity urges drug firms to reduce price of pneumonia vaccineBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6131 (Published 13 November 2015) Cite this as: BMJ 2015;351:h6131
- Anne Gulland
The charity Médecins Sans Frontières (MSF) has launched a global campaign urging drug companies GlaxoSmithKline (GSK) and Pfizer to reduce the price of the pneumonia vaccine for developing countries. The organisation launched its global petition on world pneumonia day, 12 November.
Earlier this year the charity published a report showing that the cost of fully immunising a child had increased 68 times between 2001 and 2014, while over the same period the number of vaccines in the full childhood vaccination schedule increased from six to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial